During the past decade, Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe" are "Breast Cancer" (1 trials) and "Triple Negative Breast Neoplasms" (1 trials). Many other conditions were trialed in "Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe" in a lesser frequency.

Most popular intervention types in "Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (2 trials), "Atezolizumab" (1 trials), "Carboplatin" (1 trials), "Gemcitabine" (1 trials) and "Pertuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".